Game Creek Capital, LP Abb Vie Inc. Transaction History

Game Creek Capital, LP

$214 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.24 Million - $1.54 Million	-9,375 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $308,861 - $390,798	-2,875 Reduced 23.47%	9,375 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $752,780 - $854,518	-7,075 Reduced 36.61%	12,250 $1.32 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $96,267 - $107,247	-915 Reduced 4.52%	19,325 $2.18 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $333,498 - $367,141	-3,260 Reduced 13.87%	20,240 $2.19 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $160,980 - $217,340	2,000 Added 9.3%	23,500 $2.52 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $2.24 Million - $2.63 Million	-26,125 Reduced 54.86%	21,500 $1.88 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $559,446 - $748,622	-7,625 Reduced 13.8%	47,625 $4.68 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $3.31 Million - $5.01 Million	51,250 Added 1281.25%	55,250 $4.21 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $216,390 - $270,750	-3,000 Reduced 42.86%	4,000 $354,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $47,235 - $56,790	750 Added 12.0%	7,000 $530,000
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $410,625 - $524,875	6,250 New	6,250 $455,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $302,294 - $336,056	-3,400 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 2.86%	3,400 $315,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $36,804 - $49,284	-400 Reduced 10.26%	3,500 $331,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $349,284 - $383,019	3,900	3,900 $0

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Game Creek Capital, LP with notifications on news.

Account